首页 | 本学科首页   官方微博 | 高级检索  
     


Reduced expression of the RNA‐binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27Kip1 levels and poor prognosis
Authors:Sungeun Heo  Eunbyul Ji  Jun Gi Rho  Myeongwoo Jung  Sojin Ahn  Ye‐Jin Kim  Yong‐Sung Kim  Suk Woo Nam  Rohit N Kulkarni  Kyoung Bun Lee  Eun Kyung Lee  Wook Kim
Affiliation:1. Department of Molecular Science and Technology, Ajou University, Suwon, South Korea;2. Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, South Korea;3. Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, South Korea;4. Department of Islet Cell and Regenerative Biology, Joslin Diabetes Center and Department of Medicine, Harvard Medical School and Harvard Stem Cell Institute, Boston, MA, USA;5. Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea
Abstract:For the majority of patients diagnosed with pancreatic neuroendocrine tumors (NETs), there is significant malignant potential with a poor prognosis; however, the molecular abnormalities and pathogenesis of pancreatic NETs have not been firmly established. Here, we report that loss of expression of the RNA‐binding protein HuD correlates with low p27Kip1 (p27) levels and poor prognosis in pancreatic NETs. HuD expression was frequently lost in many human pancreatic NETs, and these pancreatic NETs showed aggressive clinicopathological phenotypes with low p27 levels, increased tumor size, higher World Health Organization grade and pT stage of the tumor, and the presence of angioinvasion. Furthermore, loss of HuD was an independent, progression‐free prognostic factor in multivariate survival analysis. However, the level of HuR, a member of the same Hu protein family as HuD, was not significantly correlated with pancreatic NET size and progression. Mechanistically, HuD enhanced p27 mRNA translation by interacting with both the 5′‐untranslated region (UTR) and the 3′‐UTR of p27 mRNA, and consequently suppressed cell cycle progression and tumor growth. In addition, HuD competed with miR‐30a‐3p for binding to the 3′‐UTR of p27 mRNA, suggesting an interplay between HuD and miR‐30a‐3p in controlling p27 translation. Our results identify HuD as a pivotal suppressor of pancreatic NET growth, and suggest that HuD has potential value as a prognostic factor of pancreatic NETs. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Keywords:RNA‐binding protein  HuD  pancreatic neuroendocrine tumor  p27Kip1  prognosis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号